BioCentury
ARTICLE | Company News

UC strengthens CRISPR IP position with new patent

March 12, 2019 8:38 PM UTC

The USPTO issued a third patent covering fundamental aspects of the CRISPR-Cas9 technology to The Regents of the University of California, the University of Vienna and Emmanuelle Charpentier, strengthening the group's patent position in the highly complex IP landscape.

On Tuesday, the U.S. Patent and Trademark Office issued U.S. Patent No. 10,227,610, which describes use of CRISPR-Cas9 with a single molecule RNA guide plus Cas9 to make targeted DNA edits, specifically inside a cell. The claims are applicable to any cell type...